Red de Terapia Celular
19
1
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.3%
1 terminated/withdrawn out of 19 trials
92.9%
+6.4% vs industry average
0%
0 trials in Phase 3/4
23%
3 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
Role: lead
Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD)
Role: collaborator
Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)
Role: lead
Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells
Role: lead
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
Role: lead
Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease
Role: lead
Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)
Role: lead
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Role: lead
Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells
Role: lead
Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro
Role: lead
Use of the Amniotic Membrane in Large Wound Epithelialization
Role: lead
PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells
Role: lead
Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.
Role: lead
Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis
Role: lead
Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis
Role: lead
Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells
Role: lead
Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)
Role: lead
Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells
Role: lead
Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome
Role: collaborator
All 19 trials loaded